# E138: Dapirolizumab for SLE (PHOENYCS-GO)

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e138-dapirolizumab-for-sle-phoenycs-go
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e138-dapirolizumab-for-sle-phoenycs-go.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2026-07-24T20:33:26+00:00
Episode link: https://msputman.podbean.com/e/e138-dapirolizumab-for-sle-phoenycs-go/
Audio file: https://mcdn.podbean.com/mf/web/awsazq4j7fmzcgmw/e138.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e138-dapirolizumab-for-sle-phoenycs-go
Duration seconds: 1329

## Resource

A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The study itself was a qualified success and the podcast got a bit more rant-y than it should have been, but hopefully you get a kick out of it. Paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00691-4/fulltext

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e138-dapirolizumab-for-sle-phoenycs-go/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e138-dapirolizumab-for-sle-phoenycs-go.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.